Natural course of early COPD

Int J Chron Obstruct Pulmon Dis. 2017 Feb 20:12:663-668. doi: 10.2147/COPD.S122989. eCollection 2017.

Abstract

Background and objective: Few studies have examined the natural course of early COPD. The aim of this study was to observe the natural course of early COPD patients. We also aimed to analyze medical utilization and costs for early COPD during a 6-year period.

Methods: Patients with early COPD were selected from Korean National Health and Nutrition Examination Survey (KNHANES) data. We linked the KNHANES data of patients with early COPD to National Health Insurance data.

Results: A total of 2,397 patients were enrolled between 2007 and 2012. The mean forced expiratory volume in 1 second (FEV1) was 78.6%, and the EuroQol five dimensions questionnaire (EQ-5D) index value was 0.9. In total, 110 patients utilized health care for COPD in 2007, and this number increased to 179 in 2012. The total mean number of days used per person increased from 4.9 in 2007 to 7.8 in 2012. The total medical cost per person also increased from 248.8 US dollar (USD) in 2007 to 780.6 USD in 2013. A multiple linear regression revealed that age, lower body mass index, lower FEV1 (%), and lower EQ-5D score were significantly associated with medical costs.

Conclusion: Even in early COPD patients, some of them eventually progressed and utilized health care for COPD.

Keywords: HIRA; KNHANES; NHI; cost; early COPD; utilization.

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Body Mass Index
  • Bronchodilator Agents / economics
  • Bronchodilator Agents / therapeutic use
  • Disease Progression
  • Drug Costs
  • Emergency Service, Hospital / economics
  • Emergency Service, Hospital / statistics & numerical data
  • Female
  • Forced Expiratory Volume
  • Health Resources / economics
  • Health Resources / statistics & numerical data*
  • Health Status
  • Hospital Costs
  • Humans
  • Linear Models
  • Lung / physiopathology
  • Male
  • Middle Aged
  • Nutrition Surveys
  • Patient Admission / economics
  • Prognosis
  • Pulmonary Disease, Chronic Obstructive / diagnosis
  • Pulmonary Disease, Chronic Obstructive / economics
  • Pulmonary Disease, Chronic Obstructive / epidemiology
  • Pulmonary Disease, Chronic Obstructive / therapy*
  • Republic of Korea / epidemiology
  • Retrospective Studies
  • Surveys and Questionnaires
  • Time Factors
  • Vital Capacity

Substances

  • Bronchodilator Agents